What Is LLLT?

LLLT is a cutting-edge, non-invasive method of combating hair loss by increasing cell proliferation and giving a boost to dormant hair follicles. As a result, hair loss may be reduced and the quality and quantity of hair can be enhanced. This treatment causes no discomfort and has no negative effects.

The Food and Drug Administration has cleared LLLT for use in treating hair loss in both men and women. In most cases, it is used to treat androgenetic alopecia, often known as male or female pattern baldness.

Androgenetic alopecia is a genetic disorder that affects both sexes and causes hair follicles to gradually become smaller and more inactive, leading to hair loss.

Other kinds of alopecia and hair loss may also be treated with LLLT, including those caused by chemotherapy or by the extreme hair loss some women experience during or after pregnancy or menopause.

It is widely used in combination with other therapies for hair loss, such as PRP therapy, and may have the best results when combined with hair transplants. Long-term low-intensity focused ultrasound (LLLT) has shown results that are even more favorable than those of drugs in the short-term.